Literature DB >> 34140540

Colonic dialysis can influence gut flora to protect renal function in patients with pre-dialysis chronic kidney disease.

Yueming Li1,2, Minhui Dai3, Jianqin Yan4, Fang Liu5, Xi Wang3, Lizhen Lin6, Mei Huang6, Cuifang Li1, Rui Wen2, Jiao Qin2, Hui Xu7.   

Abstract

Chronic kidney disease (CKD) is a major public health burden around the world. The gut microbiome may contribute to CKD progression and serve as a promising therapeutic target. Colonic dialysis has long been used in China to help remove gut-derived toxins to delay CKD progression. Since disturbances in the gut biome may influence disease progression, we wondered whether colonic dialysis may mitigate the condition by influencing the biome. We compared the gut microbiota, based on 16S rRNA gene sequencing, in fecal samples of 25 patients with CKD (stages 3-5) who were receiving colonic dialysis(group CD), 25 outpatients with CKD not receiving colonic dialysis(group OP), and 34 healthy subjects(group HS). Richness of gut microbiota was similar between patients on colonic dialysis and healthy subjects, and richness in these two groups was significantly higher than that in patients not on colonic dialysis. Colonic dialysis also altered the profile of microbes in the gut of CKD patients, bringing it closer to the profile in healthy subjects. Colonic dialysis may protect renal function in pre-dialysis CKD by mitigating dysbiosis of gut microbiota.

Entities:  

Year:  2021        PMID: 34140540     DOI: 10.1038/s41598-021-91722-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  36 in total

1.  Simplified colonic dialysis with hemodialysis solutions delays the progression of chronic kidney disease.

Authors:  S Dai; Y Dai; J Peng; X Xie; J Ning
Journal:  QJM       Date:  2019-03-01

2.  Prevalence of chronic kidney disease in China: a cross-sectional survey.

Authors:  Luxia Zhang; Fang Wang; Li Wang; Wenke Wang; Bicheng Liu; Jian Liu; Menghua Chen; Qiang He; Yunhua Liao; Xueqing Yu; Nan Chen; Jian-e Zhang; Zhao Hu; Fuyou Liu; Daqing Hong; Lijie Ma; Hong Liu; Xiaoling Zhou; Jianghua Chen; Ling Pan; Wei Chen; Weiming Wang; Xiaomei Li; Haiyan Wang
Journal:  Lancet       Date:  2012-03-03       Impact factor: 79.321

3.  Chemo-Preventive Potential of Falcarindiol-Enriched Fraction from Oplopanax elatus on Colorectal Cancer Interfered by Human Gut Microbiota.

Authors:  Jin Wang; Li Shao; Tai Rao; Wei Zhang; Wei-Hua Huang
Journal:  Am J Chin Med       Date:  2019-09-05       Impact factor: 4.667

4.  Bacterial populations of the small intestine in uremia.

Authors:  M L Simenhoff; J J Saukkonen; J F Burke; L G Wesson; R W Schaedler; S J Gordon
Journal:  Nephron       Date:  1978       Impact factor: 2.847

5.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015.

Authors:  David T Gilbertson; Jiannong Liu; Jay L Xue; Thomas A Louis; Craig A Solid; James P Ebben; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 10.121

Review 6.  Bowel as a kidney substitute in renal failure.

Authors:  E A Friedman
Journal:  Am J Kidney Dis       Date:  1996-12       Impact factor: 8.860

Review 7.  The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.

Authors:  Tao Yang; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

8.  A novel alternative for renal replacement therapy: 2-year successful colonic dialysis via a Malone antegrade continent enema stoma.

Authors:  Abdol-Mohammad Kajbafzadeh; Atefeh Zeinoddini; Reza Heidari; Haleh NaserHodjjati; Ali Tourchi
Journal:  J Pediatr Urol       Date:  2013-12-04       Impact factor: 1.830

9.  Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Authors:  Paul E Stevens; Adeera Levin
Journal:  Ann Intern Med       Date:  2013-06-04       Impact factor: 25.391

10.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

View more
  1 in total

1.  Gut Bacterial Composition and Functional Potential of Tibetan Pigs Under Semi-Grazing.

Authors:  Hui Niu; Xi-Ze Feng; Chun-Wei Shi; Di Zhang; Hong-Liang Chen; Hai-Bin Huang; Yan-Long Jiang; Jian-Zhong Wang; Xin Cao; Nan Wang; Yan Zeng; Gui-Lian Yang; Wen-Tao Yang; Chun-Feng Wang
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.